Clinical Trial Update: A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating dupilumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) has completed and posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP) | Phase 3 | Status: COMPLETED | Results posted: 2019-07-25